Gudrun Weets

Gudrun Weets

Auto-generated profile, based on publicly available information

Gudrun Weets

Research and Development, Beiersdorf AG, 20245 Hamburg, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in British Journal of Dermatology
Verified
Journal Article
Open access
Shosuke ItoShosuke Ito
Shosuke Ito
LKLudger Kolbe
Ludger Kolbe
GWGudrun Weets
Gudrun Weets
TRTamara Rogers
Tamara Rogers
CBCaroline Bushdid
Caroline Bushdid
Kazumasa WakamatsuKazumasa Wakamatsu
Kazumasa Wakamatsu
Background: Hydroquinone is widely used for its hypopigmenting effects in treating hyperpigmentation disorders. However, its topical application has been linked to adverse effects, notably exogenous ochronosis, raising concerns about its safety and mechanisms of action. Objectives: To elucidate the metabolic pathway of hydroquinone in human melanocytes and to clarify the role of tyrosinase in the development of exogenous ochronosis. Methods: We conducted an in vitro investigation using human tyrosinase to analyse the metabolism of hydroquinone. The study involved assessing the oxidation of hydroquinone in the presence of L-DOPA and L-cysteine, measuring the production of dopaquinone and its subsequent derivatives, including 2-S-cysteinyl–hydroquinone (Cys-HQ) and hydroquinone–pheomelanin (HQ-PM). Results: Our findings demonstrate that human tyrosinase effectively oxidizes hydroquinone primarily via dopaquinone, with L-cysteine facilitating the formation of Cys-HQ. Further oxidation of Cys-HQ leads to the production of HQ-PM. Notably, the results indicate that tyrosinase activity is crucial for the induction of exogenous ochronosis by hydroquinone. Additionally, while high-molecular-weight hydroquinone derivatives may remain within melanosomes, low-molecular-weight metabolites can penetrate the dermis, potentially triggering the polymerization of ochronotic particles similar to those seen in exogenous ochronosis. Conclusions: Tyrosinase plays a significant role in hydroquinone-induced exogenous ochronosis, suggesting that hydroquinone acts as a ‘pseudo’ substrate for this enzyme. The findings highlight the importance of using tyrosinase inhibitors to reduce the risk of exogenous ochronosis, while cautioning against other melanogenesis inhibitors that may have similar side effects.

Verified
Journal Article
Open access
PDF file
Shosuke ItoShosuke Ito
Shosuke Ito
LKLudger Kolbe
Ludger Kolbe
TRTamara Rogers
Tamara Rogers
TMTobias Mann
Tobias Mann
GWGudrun Weets
Gudrun Weets
Kazumasa WakamatsuKazumasa Wakamatsu
Kazumasa Wakamatsu
The metabolism of hydroquinone (HQ) by tyrosinase presents significant biochemical and dermatological challenges, particularly due to its association with adverse effects such as exogenous ochronosis (EO). Despite its widespread use in skin-lightening products, the detailed mechanistic pathways of HQ metabolism by tyrosinase remain inadequately understood. This study aims to elucidate the mechanistic insights into the tyrosinase-catalyzed metabolism of HQ, leading to the production of HQ-eumelanin (HQ-EM) and HQ-pheomelanin (HQ-PM). We employed HPLC analysis to detect key intermediates and final metabolites. Results show that mushroom tyrosinase catalyzes the hydroxylation of HQ to 2-hydroxyhydroquinone (HHQ) via the 2-hydroxybenzoquinone (HBQ) pathway, giving rise to HQ-EM. However, in the presence of cysteine, a shift from HBQ to the benzoquinone (BQ) pathway occurs, giving rise to HQ-PM. Hydroiodic acid hydrolysis of HQ-PM and subsequent HPLC-electrochemical analysis identified 4-aminophenol (AP) as degradation product, thereby serving as a novel marker to monitor HQ oxidation in vitro. These results indicate that HQ functions both as a “pseudo” substrate for tyrosinase—undergoing redox exchange with dopaquinone to form BQ—and as a true substrate, yielding HBQ. This dual role contributes to the formation of HQ-EM and HQ-PM. It would be possible that EO is caused by a continuous oxidation of HQ mediated by tyrosinase activity in the skin.